Sign Up Today and Learn More About Ampersand Biomedicines Stock
Invest in or calculate the value of your shares in Ampersand Biomedicines or other pre-IPO companies through EquityZen's platform.
Ampersand Biomedicines Stock
Ampersand Biomedicines is a multi-product platform that develops programmable medicines that target disease sites precisely.
About Ampersand Biomedicines Stock
Founded
2020
Headquarters
Boston, MA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Ampersand Biomedicines Press Mentions
Stay in the know about the latest news on Ampersand Biomedicines
Compositions for facilitating membrane fusion and uses thereof
patents • Apr 02, 2025
Trem compositions and uses thereof
patents • Apr 02, 2025
Methods and compositions for modulating a genome
patents • Apr 02, 2025
Ampersand Biomedicines: Series B Raised For Developing Smarter Medicines
pulse2 • Mar 29, 2025
The Week’s Biggest Funding Rounds: Nerdio Tops Slow Week Of Raises
news • Mar 21, 2025
Ampersand Biomedicines Management
Leadership team at Ampersand Biomedicines
Co-founder and Chairman
Noubar Afeyan
CEO
Jason Gardner
Join now and verify your accreditation status to gain access to:
- Ampersand Biomedicines Current Valuation
- Ampersand Biomedicines Stock Price
- Ampersand Biomedicines Management
- Available deals in Ampersand Biomedicines and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Ampersand Biomedicines Cap Table and Funding History by Share Class and Liquidity Preferences
- Ampersand Biomedicines Revenue and Financials
- Ampersand Biomedicines Highlights
- Ampersand Biomedicines Business Model
- Ampersand Biomedicines Risk Factors
- Ampersand Biomedicines Research Report from SACRA Research
Trading Ampersand Biomedicines Stock
How to invest in Ampersand Biomedicines stock?
Accredited investors can buy pre-IPO stock in companies like Ampersand Biomedicines through EquityZen funds. These investments are made available by existing Ampersand Biomedicines shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Ampersand Biomedicines stock?
Shareholders can sell their Ampersand Biomedicines stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."